Skip to main content
OpenTrials
Completed

NCT Number: NCT05535153

Reproducibility of the Functional Movement Screen Test

The main objective of the study is to determine the inter-evaluator and intra-evaluator reproducibility of the FMS test as an evaluation tool in amateur rugby players.

The secondary objective of the study is to evaluate the abilities of the FMS test as a predictive tool for detecting possible injuries during a sports season in amateur rugby players.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Observational

Primary location

PSLA GDD

Caen, 14000, France

About this study

Rugby is a very popular sport in France, since it has more than 300,000 dismissed. The 2023 World Cup will take place in France, and in view of the enthusiasm that is created around the "XV de France" team, there will be a great number of new players. Yet there are many injuries in this sport, despite the adaptations of the French Rugby Federation. The injuries of these amateur players will handicap their performance within their club (an injured player will be injured more easily in the future) and have a impact on their personal and professional life. With this in mind, it would be desirable to have a predictive tool for possible wounds. For this, Agullo et al. had in the previous study "Reproducibility of the Functional Movement Screen (FMS) test in the amateur Rugby player" (ID-RCB: 2018-A03490-55) selected this tool already evaluated in the context of prediction injuries in other sports (hockey or American football). The FMS offers an overall assessment of the subject, based on seven so-called movements fundamentals, combining mobility and stability, making it possible to assess the deficiencies of the individual; a prevention plan will then be adapted to the subject.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Rugby players in the "Amateur" and "Senior" categories
  • Must be able to play a match within a week of the FMS test evaluation.

Exclusion criteria

  • players evolving or having evolved beyond the "Federal 3" division for men or "Federal 1" for women
  • Pregnant and breastfeeding women
  • People in an emergency situation
  • People unable to give their consent (including people under guardianship)
  • Patients already involved in another study.

Treatment and study plan

functional movement screen

Other

The volunteer subjects had to perform the FMS test at the request of the investigator, which is made up of seven movements: the squat, the crossing of the hurdle, the line lunge, the active elevation with the straight leg, a movement concerning the mobility of the shoulders, a rotational stability assessment movement and a core stability assessment movement.

Primary outcomes

  1. Functional Movement Screen

    Time frame: 1 year

    Intraclass correlation coefficient with data : FMS score between rater one and rater two

Secondary outcomes

  1. Functional Movement Screen

    Time frame: through study completion, an average of 1 year

    Functional Movement Screen (FMS) will be used as a assessment tool to screen the risk of injury in rugby

Sponsors and collaborators

Lead sponsor

Pole Sante Grace de Dieu

Other

Registry information

Official study title

Reproducibility of the Functional Movement Screen Test in the Normandy Amateur Rugby Player

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Sep 10, 2022
Registry last updated
Sep 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.